Evaluation of an anti-rPA IgG ELISA for measuring the antibody response in mice

Biologicals

Volumn 32, Issue 2, 2004, Pages 62-69

  Little, S F ^a   Webster, W M ^a   Norris, S L W ^a   Andrews, G P ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Anthrax; Enzyme linked immunosorbent assay; Recombinant vaccine

Indexed keywords

ALUMINUM HYDROXIDE; ANTHRAX VACCINE; AVA; FREUND ADJUVANT; IMMUNOGLOBULIN G ANTIBODY; PRISTANE; RECOMBINANT ANTIBODY; RECOMBINANT ANTIGEN; RECOMBINANT PROTECTIVE ANTIGEN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ACCURACY; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROLOGY;

ANIMALS; ANTHRAX VACCINES; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; BINDING, COMPETITIVE; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDIES; FEMALE; IMMUNOGLOBULIN G; LINEAR MODELS; LOGISTIC MODELS; MICE; PROTEIN BINDING; SENSITIVITY AND SPECIFICITY;

ANTHRAX;

EID: 5344277569     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biologicals.2004.02.001     Document Type: Article

References (21)

1. Ivins B.E., Welkos S.L. Recent advances in the development of an improved, human anthrax vaccine. Eur J Epidemiol. 4:1988;12-19
2. -) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infect Immun. 58:1990;303-308
3. Bradley K.A., Mogridge J., Mourez M., Collier R.J., Young J.A.T. Identification of the cellular receptor for anthrax toxin. Nature. 414:2001;225-229
4. Klimpel K.R., Molloy S.S., Thomas G., Leppla S.H. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc Natl Acad Sci U S A. 89:1992;10277-10281
5. Ezzell J.W. Jr, Abshire T.G. Serum protease cleavage of Bacillus anthracis protective antigen. J Gen Microbiol. 138:1992;543-549
6. Milne J.C., Furlong D., Hanna P.C., Wall J.S., Collier R.J. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J Biol Chem. 269:1994;20607-20612
7. Leppla SH. The anthrax toxin complex. In: Alouf JE and Freer JH (Eds). Sourcebook of bacterial protein toxins. New York: Academic Press, 1991;277-302.
8. Little S.F., Ivins B.E. Molecular pathogenesis of Bacillus anthracis infection. Microbes Infect. 2:1999;131-139
9. Habig W.H. Potency testing of bacterial vaccines for human use. Vet Microbiol. 37:1993;343-351
10. Lacy M.J., Voss E.W. Jr. A modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14 cells. J Immunol Methods. 87:1986;169-177
11. Little S.F., Leppla S.H., Cora E. Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin. Infect Immun. 56:1988;1807-1813
12. Little S.F., Novak J.M., Lowe J.R., Leppla S.H., Singh Y., Klimpel K.R., et al. Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies. Microbiology. 142:1996;707-715
13. Shrout P., Fleiss J. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 86:1979;420-428
14. O'Connell M., Belanger B., Haaland P. Calibration and assay development using the four-parameter logistic model. Chemom Intell Lab Sys. 20:1993;97-114
15. Plikaytis B.D., Holder P.F., Pais L.B., Maslanka S.E., Gheesling L.L., Carlone G.M. Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol. 32:1994;2441-2447
16. Pittman P.R., Kim-Ahn G., Pifat D.Y., Coonan K., Gibbs P., Little S., et al. Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans. Vaccine. 20:2002;1412-1420
17. Pitt M.L.M., Little S.F., Ivins B.E., Fellows P., Barth J., Hewetson J.G.P., et al. In vitro correlate of immunty in a rabbit model of inhalational anthrax. Vaccine. 19:2001;4768-4773
18. Jennings V.M. Review of selected adjuvants used in antibody production. ILAR J. 37:1995;119-124
19. Hollander Z., Katchalski-Katzir E. Use of monoclonal antibodies to detect conformational alterations in lactate dehydrogenase isoenzyme 5 on heat denaturation and on adsorption to polystyrene plates. Mol Immunol. 23:1986;927-933
20. Jitsukawa T., Nakajima S., Sugawara I., Watanabe H. Increased coating efficiency of antigens and preservation of original antigenic structure after coating in ELISA. J Immunol Methods. 116:1989;251-257
21. Vaidya H.C., Dietzler D.N., Ladenson J.H. Inadequacy of traditional ELISA for screening hybridoma subernatants for murine monoclonal antibodies. Hybridoma. 4:1985;271-276